As the deadly Clostridium difficile bacterium (C. diff) sweeps the nation, we are warned that it’s our own fault. The overuse of antibiotics has wiped out the ‘good’ bacteria living inside our digestive system and set the stage for C. diff to spread rampantly across the nation.
Clostridium difficile bacterium sets up shop inside the digestive system and causes severe diarrhea. In some cases, the C. diff has proved to be fatal. The deadly diarrhea-causing bacteria is spread via person to person contact and is spreading uncontrollably in doctors’ offices, hospitals and nursing homes. The deadly infection comes from a particularly dangerous strain of bacteria, NAP1, which is resistant to most all antibiotics.
That resistance is due to the overuse of antibiotics in America. This deadly strain of bacteria mutated and became stronger with each attempt to kill it with antibiotics. C. diff was able to take a toehold in society because the various antibiotics prescribed for minor problems wiped out the good bacteria that is needed in the digestive system. The good bacteria attacks invading, illness-causing germs before they can set up shop and wreak havoc within the digestive system. But with no good bacteria in the gut to do its job, the C. diff has an open invitation to destroy.
Zeca Oliveira(noticias.uol.com) has read that The Clostridium difficile bacterium creates such destruction with the digestive tract, that the bowels are often damaged and some of the colon must be removed. That is if the patient survives the onslaught of diarrhea.
We’ve heard much about the measles outbreak and anti-vaxxers recently, but Ricardo Guimarães BMG says that no notice has been taken of another group of potential measles carriers and spreaders; teachers and school staff.
These people come into contact with our children five days a week, so just what are the rules regarding measles vaccines for teachers, para-pros, lunch room workers, school secretary, principal, vice principal and all the other adults in the public and private school setting?
Most states do not have a law requiring teachers and school staff to receive certain vaccines. Some states provide school personnel with a list of vaccines they want them to get, but the state does not do any type of follow up to ensure the educators and staff receive the vaccines before coming into direct daily contact with your child.
Parents of school-aged children are required to provide a proof of immunization record (or reason for being an anti-vaxxer) before entering the school system. So if/when a contagious disease breaks out within the school system, it’s easy to pull the records and see who has had their required vaccinations and who has not.
Teachers and school staff are not required to have an immunization record on file. It’s just assumed that those who have been educated to educate our children would be up-to-date on their immunizations. That assumption is wrong. The adults who spend hours each day with our children may be the catalyst for the spread of measles and other contagious diseases because they have not been immunized.
While many who work in biotechnology or who are actively involved in life sciences in the world of academics are well aware of who Mark Ahn is, those who are outside of these communities in the public and private sector are not aware of the incredible contributions he has made to his field. Ahn is a highly accomplished biotechnology professional and academic, and his efforts in both the public and private sectors have been integral in transforming the industry. One of the many areas that he has achieved great success relates to the area of breast cancer research.
The Professional Life of Mark Ahn
Ahn is a highly educated biotechnology professional, and he also has more than two decades of professional work experience in high-level positions. His education includes degrees earned at schools like the University of South Australia, Chaminade University, Aspen Institute and other reputable schools. He also has worked in high level positions, including as president or CEO in some cases, at companies such as Bristol-Myers Squibb Company, Hana Biosciences, Genentech, Amgen and others. At each of these and other companies, his efforts have resulted in excellent research and innovations. Notably, at Galena Biopharma he played a role in research and clinical studies in the area of breast cancer research.
A Closer Look at Breast Cancer Research
Galena received a grant from the Department of Defense that providing a significant amount of funding for a clinical trial on breast cancer medication. The trial was in conjunction with NeuVax, and it focused on preventing the development of breast cancer in high risk patients. The funding provided for expanded research based on what was already taking place. In addition, he worked to secure a patent in the United States for the NeuVax breast cancer prevention medication that was being developed at the time. The studies and research are going well, and this is a medication that has the potential to save many lives going forward.
In a biotechnology firm that conducts research and that completes clinical studies, it generally is the work of a team of highly skilled and knowledgeable professionals who work collaboratively to bring about change. However, with a lead role in the company and with a proven desire to change the world through his efforts in all of his public and private roles over the course of his career, it is clear that Ahn will continue to be instrumental in the area of breast cancer research and other areas that he is currently focusing his efforts on.
Melissa Carleton fell into a coma backing March due to a benign brain tumor which caused a seizure. She was kept in a coma at until her baby made it to full term. She delivered her son, West Nataniel Lande, by C-section, in May.
Since delivering her baby, Melissa has woken up from her coma. However, she spent months in the hospital. After being in the hospital for months, she was moved to her parents home, where she was provided with around the clock care according to Bruce Levenson.
She is finally getting to go home and live with her husband again. Which has to be a relief, as he has been commuting 4 ½ hours between where his home and job are located and where her parents live and where she stayed in the hospital.
Right in time to celebrate her son’s first Christmas, Melissa is finally going home. The Saturday after Christmas was the first time she had seen her son in over two months. Right now, Melissa is able to be alert and respond to things happening around her. She is also able to move her feet. However, just like her newborn son, Melissa is going to have to learn how to walk, talk, eat and perform basic functions again. She is technically in a minimally conscious state, and has been fighting to get back. She has a long road in front of her before she is even ready to enter a rehabilitation facility. Her family is hopefully that she will continue to recover and are thankful for all the support they have received
The death rate of infants deemed premature because they were born before the 37th week of pregnancy has been definitely lowered in America, but work still needs to be done. This is the 7th year the death rate has lowered, meeting the federal Healthy People 2020 goal 7 years early. But America still rates a C in mortality rates for preterm deaths in the world. In 2012 the preterm death rate was so bad it was the same as Somalia’s preterm death rate. Rating 131st out of 184.
So why the high mortality rate? It is attributed to lack of healthcare insurance. Preterm babies need extensive medical care and therapies with the majority of deaths being contributed to not being able to receive proper care. Another factor of preterm deaths is the fact women were choosing to have c-sections preterm, but thankfully that trend has slowed. That also may be a contributing factor to the death rate lowering.
Some states such as New Hampshire, Maine, Vermont, Oregon and California did rate A’s in the ability to save more preterm babies. While Louisiana, Alabama, and Mississippi had an F rating. In Mississippi almost a quarter of preterm deaths were to uninsured mothers. The cost of having a preterm baby is around $54,000 in care and treatment while a healthy newborn only costs about $4,000.
Big thanks to friend of the site Jared Haftel for this happy news tip!
I remember when I was 5 or 6 and my mom gave me cough syrup. I ran away from her and hid all over the house just like the kid in the commercial. The cherry flavor did not taste like cherries, and the grape flavor certainly did not taste like grapes. Today, when my child gets a cold or a cough, I try the same cough syrups, and by the smell of them, I know they taste the same. Do they work? Scientists are now saying that they may not work any better than a placebo.
In a recent study conducted by the Penn State College of Medicine, kids with colds and coughs were given a placebo cough syrup made of agave nectar. The consistency was the same as those cough syrups we usually use, but of course, there was no value in the syrup that could contribute to healing a cough.
The findings produced showed clearly that this placebo worked just as well for children’s coughs as the real cough syrups did. The team of researchers are now suggesting that parents try this placebo syrup at home, but they do recommend that children see doctors first and that the doctors actually prescribe this method of treatment.
Big thanks to mom Susan McGalla for introducing me this good news for kids and parents alike.